Global Neurodegenerative Disease Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
- MAI4610550
- 109 Pages
- August 2021
- BFSI
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Neurodegenerative Disease market covered in Chapter 5:
Merck and Co. Inc.
AbbVie Inc.
Amneal Pharmaceuticals Inc.
Teva Pharmaceutical
F. Hoffmann-La Roche Ltd
UCB SA
Boehringer Ingelheim Group
GlaxoSmithKline Plc
Pfizer Inc.
In Chapter 6, on the basis of types, the Neurodegenerative Disease market from 2015 to 2025 is primarily split into:
N-methyl-D-aspartate Receptor
Selective Serotonin Reuptake Inhibitor
Dopamine Inhibitors
In Chapter 7, on the basis of applications, the Neurodegenerative Disease market from 2015 to 2025 covers:
Hospital
Clinic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Neurodegenerative Disease Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 Analysis of Leading Companies
5.1 Merck and Co. Inc.
5.1.1 Merck and Co. Inc. Company Profile
5.1.2 Merck and Co. Inc. Business Overview
5.1.3 Merck and Co. Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Merck and Co. Inc. Neurodegenerative Disease Products Introduction
5.2 AbbVie Inc.
5.2.1 AbbVie Inc. Company Profile
5.2.2 AbbVie Inc. Business Overview
5.2.3 AbbVie Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 AbbVie Inc. Neurodegenerative Disease Products Introduction
5.3 Amneal Pharmaceuticals Inc.
5.3.1 Amneal Pharmaceuticals Inc. Company Profile
5.3.2 Amneal Pharmaceuticals Inc. Business Overview
5.3.3 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Amneal Pharmaceuticals Inc. Neurodegenerative Disease Products Introduction
5.4 Teva Pharmaceutical
5.4.1 Teva Pharmaceutical Company Profile
5.4.2 Teva Pharmaceutical Business Overview
5.4.3 Teva Pharmaceutical Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Teva Pharmaceutical Neurodegenerative Disease Products Introduction
5.5 F. Hoffmann-La Roche Ltd
5.5.1 F. Hoffmann-La Roche Ltd Company Profile
5.5.2 F. Hoffmann-La Roche Ltd Business Overview
5.5.3 F. Hoffmann-La Roche Ltd Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 F. Hoffmann-La Roche Ltd Neurodegenerative Disease Products Introduction
5.6 UCB SA
5.6.1 UCB SA Company Profile
5.6.2 UCB SA Business Overview
5.6.3 UCB SA Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 UCB SA Neurodegenerative Disease Products Introduction
5.7 Boehringer Ingelheim Group
5.7.1 Boehringer Ingelheim Group Company Profile
5.7.2 Boehringer Ingelheim Group Business Overview
5.7.3 Boehringer Ingelheim Group Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Boehringer Ingelheim Group Neurodegenerative Disease Products Introduction
5.8 GlaxoSmithKline Plc
5.8.1 GlaxoSmithKline Plc Company Profile
5.8.2 GlaxoSmithKline Plc Business Overview
5.8.3 GlaxoSmithKline Plc Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 GlaxoSmithKline Plc Neurodegenerative Disease Products Introduction
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Company Profile
5.9.2 Pfizer Inc. Business Overview
5.9.3 Pfizer Inc. Neurodegenerative Disease Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Pfizer Inc. Neurodegenerative Disease Products Introduction
6 Market Analysis and Forecast, By Product Types
6.1 Global Neurodegenerative Disease Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Neurodegenerative Disease Sales and Market Share by Types (2015-2020)
6.1.2 Global Neurodegenerative Disease Revenue and Market Share by Types (2015-2020)
6.1.3 Global Neurodegenerative Disease Price by Types (2015-2020)
6.2 Global Neurodegenerative Disease Market Forecast by Types (2020-2025)
6.2.1 Global Neurodegenerative Disease Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Neurodegenerative Disease Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Neurodegenerative Disease Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Neurodegenerative Disease Sales, Price and Growth Rate of N-methyl-D-aspartate Receptor
6.3.2 Global Neurodegenerative Disease Sales, Price and Growth Rate of Selective Serotonin Reuptake Inhibitor
6.3.3 Global Neurodegenerative Disease Sales, Price and Growth Rate of Dopamine Inhibitors
6.4 Global Neurodegenerative Disease Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 N-methyl-D-aspartate Receptor Market Revenue and Sales Forecast (2020-2025)
6.4.2 Selective Serotonin Reuptake Inhibitor Market Revenue and Sales Forecast (2020-2025)
6.4.3 Dopamine Inhibitors Market Revenue and Sales Forecast (2020-2025)
7 Market Analysis and Forecast, By Applications
7.1 Global Neurodegenerative Disease Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Neurodegenerative Disease Sales and Market Share by Applications (2015-2020)
7.1.2 Global Neurodegenerative Disease Revenue and Market Share by Applications (2015-2020)
7.2 Global Neurodegenerative Disease Market Forecast by Applications (2020-2025)
7.2.1 Global Neurodegenerative Disease Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Neurodegenerative Disease Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Neurodegenerative Disease Revenue, Sales and Growth Rate of Hospital (2015-2020)
7.3.2 Global Neurodegenerative Disease Revenue, Sales and Growth Rate of Clinic (2015-2020)
7.4 Global Neurodegenerative Disease Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Hospital Market Revenue and Sales Forecast (2020-2025)
7.4.2 Clinic Market Revenue and Sales Forecast (2020-2025)
8 Market Analysis and Forecast, By Regions
8.1 Global Neurodegenerative Disease Sales by Regions (2015-2020)
8.2 Global Neurodegenerative Disease Market Revenue by Regions (2015-2020)
8.3 Global Neurodegenerative Disease Market Forecast by Regions (2020-2025)
9 North America Neurodegenerative Disease Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
9.3 North America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
9.4 North America Neurodegenerative Disease Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Neurodegenerative Disease Market Analysis by Country
9.6.1 U.S. Neurodegenerative Disease Sales and Growth Rate
9.6.2 Canada Neurodegenerative Disease Sales and Growth Rate
9.6.3 Mexico Neurodegenerative Disease Sales and Growth Rate
10 Europe Neurodegenerative Disease Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
10.3 Europe Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
10.4 Europe Neurodegenerative Disease Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Neurodegenerative Disease Market Analysis by Country
10.6.1 Germany Neurodegenerative Disease Sales and Growth Rate
10.6.2 United Kingdom Neurodegenerative Disease Sales and Growth Rate
10.6.3 France Neurodegenerative Disease Sales and Growth Rate
10.6.4 Italy Neurodegenerative Disease Sales and Growth Rate
10.6.5 Spain Neurodegenerative Disease Sales and Growth Rate
10.6.6 Russia Neurodegenerative Disease Sales and Growth Rate
11 Asia-Pacific Neurodegenerative Disease Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Neurodegenerative Disease Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Neurodegenerative Disease Market Analysis by Country
11.6.1 China Neurodegenerative Disease Sales and Growth Rate
11.6.2 Japan Neurodegenerative Disease Sales and Growth Rate
11.6.3 South Korea Neurodegenerative Disease Sales and Growth Rate
11.6.4 Australia Neurodegenerative Disease Sales and Growth Rate
11.6.5 India Neurodegenerative Disease Sales and Growth Rate
12 South America Neurodegenerative Disease Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
12.3 South America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
12.4 South America Neurodegenerative Disease Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Neurodegenerative Disease Market Analysis by Country
12.6.1 Brazil Neurodegenerative Disease Sales and Growth Rate
12.6.2 Argentina Neurodegenerative Disease Sales and Growth Rate
12.6.3 Columbia Neurodegenerative Disease Sales and Growth Rate
13 Middle East and Africa Neurodegenerative Disease Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Neurodegenerative Disease Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Neurodegenerative Disease Market Analysis by Country
13.6.1 UAE Neurodegenerative Disease Sales and Growth Rate
13.6.2 Egypt Neurodegenerative Disease Sales and Growth Rate
13.6.3 South Africa Neurodegenerative Disease Sales and Growth Rate
14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 Appendix
15.1 Methodology
15.2 Research Data Source
List of Tables and Figures
Figure Product Picture
Figure Global Neurodegenerative Disease Market Size and Growth Rate 2015-2025
Table Neurodegenerative Disease Key Market Segments
Figure Global Neurodegenerative Disease Market Revenue ($) Segment by Type from 2015-2020
Figure Global Neurodegenerative Disease Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Neurodegenerative Disease
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Merck and Co. Inc. Company Profile
Table Merck and Co. Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck and Co. Inc. Production and Growth Rate
Figure Merck and Co. Inc. Market Revenue ($) Market Share 2015-2020
Table AbbVie Inc. Company Profile
Table AbbVie Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure AbbVie Inc. Production and Growth Rate
Figure AbbVie Inc. Market Revenue ($) Market Share 2015-2020
Table Amneal Pharmaceuticals Inc. Company Profile
Table Amneal Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amneal Pharmaceuticals Inc. Production and Growth Rate
Figure Amneal Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Teva Pharmaceutical Company Profile
Table Teva Pharmaceutical Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Teva Pharmaceutical Production and Growth Rate
Figure Teva Pharmaceutical Market Revenue ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd Company Profile
Table F. Hoffmann-La Roche Ltd Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffmann-La Roche Ltd Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd Market Revenue ($) Market Share 2015-2020
Table UCB SA Company Profile
Table UCB SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure UCB SA Production and Growth Rate
Figure UCB SA Market Revenue ($) Market Share 2015-2020
Table Boehringer Ingelheim Group Company Profile
Table Boehringer Ingelheim Group Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Boehringer Ingelheim Group Production and Growth Rate
Figure Boehringer Ingelheim Group Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Plc Company Profile
Table GlaxoSmithKline Plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Plc Production and Growth Rate
Figure GlaxoSmithKline Plc Market Revenue ($) Market Share 2015-2020
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Market Revenue ($) Market Share 2015-2020
Table Global Neurodegenerative Disease Sales by Types (2015-2020)
Table Global Neurodegenerative Disease Sales Share by Types (2015-2020)
Table Global Neurodegenerative Disease Revenue ($) by Types (2015-2020)
Table Global Neurodegenerative Disease Revenue Share by Types (2015-2020)
Table Global Neurodegenerative Disease Price ($) by Types (2015-2020)
Table Global Neurodegenerative Disease Market Forecast Sales by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Sales Share by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Types (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue Share by Types (2020-2025)
Figure Global N-methyl-D-aspartate Receptor Sales and Growth Rate (2015-2020)
Figure Global N-methyl-D-aspartate Receptor Price (2015-2020)
Figure Global Selective Serotonin Reuptake Inhibitor Sales and Growth Rate (2015-2020)
Figure Global Selective Serotonin Reuptake Inhibitor Price (2015-2020)
Figure Global Dopamine Inhibitors Sales and Growth Rate (2015-2020)
Figure Global Dopamine Inhibitors Price (2015-2020)
Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of N-methyl-D-aspartate Receptor (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of N-methyl-D-aspartate Receptor (2020-2025)
Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Selective Serotonin Reuptake Inhibitor (2020-2025)
Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Dopamine Inhibitors (2020-2025)
Table Global Neurodegenerative Disease Sales by Applications (2015-2020)
Table Global Neurodegenerative Disease Sales Share by Applications (2015-2020)
Table Global Neurodegenerative Disease Revenue ($) by Applications (2015-2020)
Table Global Neurodegenerative Disease Revenue Share by Applications (2015-2020)
Table Global Neurodegenerative Disease Market Forecast Sales by Applications (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Sales Share by Applications (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Hospital Sales and Growth Rate (2015-2020)
Figure Global Hospital Price (2015-2020)
Figure Global Clinic Sales and Growth Rate (2015-2020)
Figure Global Clinic Price (2015-2020)
Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Hospital (2020-2025)
Figure Global Neurodegenerative Disease Market Revenue ($) and Growth Rate Forecast of Clinic (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate Forecast of Clinic (2020-2025)
Figure Global Neurodegenerative Disease Sales and Growth Rate (2015-2020)
Table Global Neurodegenerative Disease Sales by Regions (2015-2020)
Table Global Neurodegenerative Disease Sales Market Share by Regions (2015-2020)
Figure Global Neurodegenerative Disease Sales Market Share by Regions in 2019
Figure Global Neurodegenerative Disease Revenue and Growth Rate (2015-2020)
Table Global Neurodegenerative Disease Revenue by Regions (2015-2020)
Table Global Neurodegenerative Disease Revenue Market Share by Regions (2015-2020)
Figure Global Neurodegenerative Disease Revenue Market Share by Regions in 2019
Table Global Neurodegenerative Disease Market Forecast Sales by Regions (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Sales Share by Regions (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Neurodegenerative Disease Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure North America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
Figure North America Neurodegenerative Disease Market Forecast Sales (2020-2025)
Figure North America Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Canada Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Mexico Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Europe Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Europe Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
Figure Europe Neurodegenerative Disease Market Forecast Sales (2020-2025)
Figure Europe Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure France Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Italy Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Spain Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Russia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Neurodegenerative Disease Market Forecast Sales (2020-2025)
Figure Asia-Pacific Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Japan Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure South Korea Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Australia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure India Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure South America Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure South America Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
Figure South America Neurodegenerative Disease Market Forecast Sales (2020-2025)
Figure South America Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)
Figure Brazil Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Argentina Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Columbia Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Neurodegenerative Disease Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Neurodegenerative Disease Market Forecast Sales (2020-2025)
Figure Middle East and Africa Neurodegenerative Disease Market Forecast Revenue ($) (2020-2025)
Figure UAE Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure Egypt Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Figure South Africa Neurodegenerative Disease Market Sales and Growth Rate (2015-2020)
Similar Reports
Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...
- Publish Date: July 31, 2017
- $5370
ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...
- Publish Date: March 1, 2016
- $3390
The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...
- Publish Date: January 15, 2016
- $2800
